Objective: To analyze current evidence comparing the safety and outcomes of regional and global ischemia for partial nephrectomy (PN). Materials and Methods: A systematic search of the PubMed and Web of Science databases was conducted in May 2014 to identify studies comparing the safety and outcomes of regional and global ischemia for PN. A systematic review and meta-analysis was also performed. Results: Six retrospective observational studies were selected for the analysis, including 363 patients who underwent PN (162 regional ischemia and 201 global ischemia cases). Operation times were not statistically different [weighted mean difference (WMD) = 20.35 min, 95% CI: -0.28-40.97, p = 0.05], but estimated blood loss was significantly higher in the regional ischemia group (WMD = 52.04 ml, 95% CI: 14.30-89.78, p = 0.007) than in the global ischemia group. Complication rates [odds ratio (OR) = 1.16; 95% CI: 0.63-2.15, p = 0.63] and blood transfusion rates (OR = 1.85; 95% CI: 0.86-4.01, p = 0.12) of the two groups were not significantly different. The regional ischemia group showed better postoperative renal function (WMD = 4.23 ml/min, 95% CI: 2.61-5.85, p < 0.00001) than the global ischemia group, and all cases in the regional ischemia group showed negative margins. Conclusions: Regional ischemia is as safe to perform as global ischemia, and the former leads to better postoperative renal functions than the latter. These findings support the application of regional ischemia for PN.

Keywords:
Ischemia, Meta-analysis, Nephrectomy, Reperfusion injury
1.
Gill IS, Aron M, Gervais DA, Jewett MA: Clinical practice. Small renal mass. N Engl J Med 2010;362:624-634.
2.
Heuer R, Gill IS, Guazzoni G, Kirkali Z, Marberger M, Richie JP, de la Rosette JJ: A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol 2010;57:223-232.
3.
Volpe A, Amparore D, Mottrie A: Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol 2013;23:403-410.
4.
Leslie S, Goh AC, Gill IS: Partial nephrectomy - contemporary indications, techniques and outcomes. Nat Rev Urol 2013;10:275-283.
5.
Arceo-Olaiz R, de la Morena JM, Hernandez V, Llorente C: The role of ischemia in the deterioration of renal function after partial nephrectomy. Arch Esp Urol 2013;66:350-358.
6.
Nguyen MM, Gill IS: Halving ischemia time during laparoscopic partial nephrectomy. J Urol 2008;179:627-632, discussion 632.
7.
Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC: Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012;79:356-360.
8.
Shao P, Qin C, Yin C, Meng X, Ju X, Li J, Lv Q, Zhang W, Xu Z: Laparoscopic partial nephrectomy with segmental renal artery clamping: technique and clinical outcomes. Eur Urol 2011;59:849-855.
9.
Gill IS, Eisenberg MS, Aron M, Berger A, Ukimura O, Patil MB, Campese V, Thangathurai D, Desai MM: ‘Zero ischemia' partial nephrectomy: novel laparoscopic and robotic technique. Eur Urol 2011;59:128-134.
10.
Xu Y, Shao P, Zhu X, Lv Q, Liu W, Xu H, Zhu Y, Yang G, Tang L, Yin C: Three-dimensional renal CT angiography for guiding segmental renal artery clamping during laparoscopic partial nephrectomy. Clin Radiol 2013;68: e609-e616.
11.
Tobis S, Knopf J, Silvers C, Yao J, Rashid H, Wu G, Golijanin D: Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for renal cortical tumors. J Urol 2011;186:47-52.
12.
Patil MB, Lee DJ, Gill IS: Eliminating global renal ischemia during partial nephrectomy: an anatomical approach. Curr Opin Urol 2012;22:83-87.
13.
Clarke M, Horton R: Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 2001;357:1728.
14.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
15.
DerSimonian R, Kacker R: Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007;28:105-114.
16.
Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
17.
Harke N, Schoen G, Schiefelbein F, Heinrich E: Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: a single-surgeon matched-pair study. World J Urol 2014;32:1259-1265.
18.
Borofsky MS, Gill IS, Hemal AK, Marien TP, Jayaratna I, Krane LS, Stifelman MD: Near-infrared fluorescence imaging to facilitate super-selective arterial clamping during zero-ischaemia robotic partial nephrectomy. BJU Int 2013;111:604-610.
19.
Desai MM, de Castro AA, Leslie S, Cai J, Huang EY, Lewandowski PM, Lee D, Dharmaraja A, Berger AK, Goh A, Ukimura O, Aron M, Gill IS: Robotic partial nephrectomy with superselective versus main artery clamping: a retrospective comparison. Eur Urol 2014;66:713-719.
20.
Nohara T, Fujita H, Yamamoto K, Kitagawa Y, Gabata T, Namiki M: Modified anatrophic partial nephrectomy with selective renal segmental artery clamping to preserve renal function: a preliminary report. Int J Urol 2008;15:961-966.
21.
Martin GL, Warner JN, Nateras RN, Andrews PE, Humphreys MR, Castle EP: Comparison of total, selective, and nonarterial clamping techniques during laparoscopic and robot-assisted partial nephrectomy. J Endourol 2012;26:152-156.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.